| Title |
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007)
|
|---|---|
| Published in |
Infectious Diseases and Therapy, June 2019
|
| DOI | 10.1007/s40121-019-0251-4 |
| Pubmed ID | |
| Authors |
Joseph L. Kuti, Aryun Kim, Daniel J. Cloutier, David P. Nicolau |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 23% |
| Spain | 2 | 8% |
| Saint Lucia | 1 | 4% |
| United Kingdom | 1 | 4% |
| Argentina | 1 | 4% |
| Mexico | 1 | 4% |
| Guatemala | 1 | 4% |
| South Africa | 1 | 4% |
| Peru | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 10 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 65% |
| Scientists | 7 | 27% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 51 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 14% |
| Researcher | 5 | 10% |
| Student > Ph. D. Student | 4 | 8% |
| Student > Doctoral Student | 3 | 6% |
| Professor | 3 | 6% |
| Other | 6 | 12% |
| Unknown | 23 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 20% |
| Medicine and Dentistry | 8 | 16% |
| Immunology and Microbiology | 4 | 8% |
| Business, Management and Accounting | 2 | 4% |
| Environmental Science | 1 | 2% |
| Other | 4 | 8% |
| Unknown | 22 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.
All research outputs
#2,618,760
of 25,392,205 outputs
Outputs from Infectious Diseases and Therapy
#118
of 827 outputs
Outputs of similar age
#52,545
of 357,667 outputs
Outputs of similar age from Infectious Diseases and Therapy
#2
of 11 outputs
Altmetric has tracked 25,392,205 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 827 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,667 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.